Cancer News and Research

Latest Cancer News and Research

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

A subanalysis of the phase III ALEX study has shown that alectinib 600 mg twice daily is more effective than standard of care crizotinib in Asian patients with anaplastic lymphoma kinase (ALK) positive non-small-cell lung cancer (NSCLC), researchers report at the ESMO Asia 2017 Congress.

20 Nov 2017

Osimertinib provides progression-free survival benefit to Asian patients with EGFR-mutated NSCLC

Osimertinib improves progression-free survival compared to standard first line therapy in Asian patients with EGFR-mutated non-small-cell lung cancer (NSCLC), according to the Asian subset analysis of the FLAURA trial presented at the ESMO Asia 2017 Congress, sumultaneously published in The New England Journal of Medicine.

20 Nov 2017

All mouth cancer patients in Myanmar use smokeless tobacco, study finds

A study in Myanmar has found that all mouth cancer patients use smokeless tobacco, researchers report at the ESMO Asia 2017 Congress. Betel quid chewing often starts in adolescence and is associated with smoking and drinking alcohol, which are also risk factors for oral cancer.

20 Nov 2017

Indonesian study finds low rates of awareness about cervical and breast cancer screening

Just one in five Indonesian women are aware of cervical cancer screening, according to a study presented at the ESMO Asia 2017 Congress. The research in nearly 5,400 women also found that only 5% knew about mammography for early detection of breast cancer.

20 Nov 2017

Study highlights need for more effective approaches to provide cancer survivorship care

Cancer-related effects and the treatment itself can have a significant psychosocial impact on cancer survivors. A recent study (STEP study) that assessed over 1800 cancer survivors across ten countries in Asia Pacific was presented at the ESMO Asia Congress today.

20 Nov 2017

Study confirms safety and efficacy of new second line treatment for metastatic colorectal cancer

A randomized trial in 650 patients has confirmed the safety and efficacy of a new second line treatment for metastatic colorectal cancer, researchers report at the ESMO Asia 2017 Congress.

20 Nov 2017

Australian government urged to sue tobacco companies

First it was Canada and now Australian state and federal governments are being urged to go ahead and sue to tobacco companies. Billions of dollars are being spent in treating tobacco-related diseases and ailments of the general public and some of it could be compensated this way feel experts.

19 Nov 2017

Study shows how naïve T-cells may affect tumor immunity and immunotherapy

The immune cells that are trained to fight off the body's invaders can become defective. It's what allows cancer to develop. So most research has targeted these co-called effector T-cells.

17 Nov 2017

Mount Sinai researchers identify new therapeutic target for ER+ breast cancer

Researchers at the Icahn School of Medicine at Mount Sinai have identified a protein that can be targeted to suppress growth of a common type of breast cancer known as "estrogen receptor positive" (ER+), including ER+ cancers that are resistant to standard treatments.

17 Nov 2017

Cancer News and Research

Latest Cancer News and Research

Study: Alectinib 600 mg more effective than standard therapy in Asian ALK positive NSCLC patients

Osimertinib provides progression-free survival benefit to Asian patients with EGFR-mutated NSCLC

All mouth cancer patients in Myanmar use smokeless tobacco, study finds

Indonesian study finds low rates of awareness about cervical and breast cancer screening

Study highlights need for more effective approaches to provide cancer survivorship care

Study confirms safety and efficacy of new second line treatment for metastatic colorectal cancer

Australian government urged to sue tobacco companies

Study shows how naïve T-cells may affect tumor immunity and immunotherapy

Mount Sinai researchers identify new therapeutic target for ER+ breast cancer

Researchers find way to switch tumor cells between 2D and 3D morphology

Regular light physical activity may reduce mortality risk in older women

Groundbreaking study identifies protein as potential factor in cancer metastasis

Old World monkeys could hold key to stop progression of rheumatoid arthritis

Majority of people do not understand link between obesity and cancer, study shows

Drug used to prevent and treat malaria may also be effective for Zika virus

FDA approves first adjuvant treatment to reduce risk of kidney cancer recurrence

FAIMS technology holds potential to be effective screening tool for pancreatic cancer

Breakthrough research brings new procedure closer to helping patients with blood cancer

ATS debuts new video to highlight dangers of flavored tobacco

Medicare seeks comment on ways to cut costs of Part D drugs

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in